Single-use bioprocessing technology consists of disposable products that assist in manufacturing biopharmaceutical products. This technology has been rapidly adopted by various biopharmaceutical companies in the recent years. These technologies are applied in monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and other applications. The key factors that drive the market growth include rise in adoption of single use technologies, low risk of product cross contamination, cost-effectiveness, and less floor space requirement. The global single-use bioprocessing market was valued at $2,800 million in 2016, and is expected to reach $9,342 million by 2023, registering a CAGR of 18.7% from 2017 to 2023.
The global single-use bioprocessing market is segmented on the basis of product, application, method, end user, and geography. Based on product, it is divided into bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags & containers, mixing systems, tubing assemblies, sampling systems, and other products. Based on application, it is classified into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. Based on method, it is categorized into filtration, storage, cell culture, mixing, and purification. Based on end user, it is classified into biopharmaceutical manufacturers, life science R&D companies & academic research institutes, and contract research organizations & manufacturers. The media bags & assemblies segment generated the highest revenue in 2016, registering a CAGR of 18.1% from 2017 to 2023, and is anticipated to continue its dominance throughout the forecast period. In addition, single-use bioprocessing technologies are used in the production of monoclonal antibodies (mAb), and has generated the highest revenue in this application throughout the forecast period.
Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In the recent years, Asia-Pacific has witnessed rapid growth in the single-use bioprocessing market This is attributed to the increasing adoption of single-use technologies by small biotechnology startups and biopharmaceutical companies in bioprocessing. In addition, several market players have focused on developing novel single use products for bio-manufacturing driving the market growth.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global single-use bioprocessing market along with the current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
Comprehensive quantitative analysis of the industry is provided for the period of 2016-2023 to assist stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps in understanding the trends in products and technologies across the globe.
Key market players and their strategies have been provided to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By Product
Bioreactors
Tangential-flow Filtration Devices
Depth Filters
Disposable Filter Cartridges
Media Bags & Containers
Mixing Systems
Tubing Assemblies
Sampling Systems
Other Products
By Method
Filtration
Storage
Cell Culture
Mixing
Purification
By Application
Monoclonal Antibody Production
Vaccine Production
Plant Cell Cultivation
Patient Specific Cell Therapies
Other Applications
By End User
Biopharmaceutical Manufacturers
Life Science R&D Companies & Academic Research Institutes
Contract Research Organizations & Manufacturers
By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Argentina
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
Thermo Fisher Scientific
Danaher Corporation
GE Healthcare (General Electric Company)
Sartorius Stedim Biotech S.A.
Merck Millipore (Merck Group)
3M Company
Eppendorf AG
Finesse Solutions, Inc.
Applikon Biotechnology B.V.
Cesco Bioengineering Co., Ltd.
The other players in the value chain include (profiles not included in the report)
Octane Biotech Inc.
PBS Biotech, Inc.
Meissner Filtration Products, Inc.
Sentinel Process Systems Inc.
CMC Biologics (Asahi Glass Co.)
Novasep
PendoTECH
BioPure Technology Ltd.
